2 completed. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 2 |
Follow Pergolide: new trials by email Literature Review of Pergolide trials Research Report on Pergolide
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| MOTION, Safinamide in Early IPD, as add-on to Dopamine Agonist Safinamide (as add-on therapy) - Idiopathic Parkinson's Disease | Phase 3 | Completed | Newron Pharmaceuticals SPA | 679 | 2007-11-01 | 2013-10-29 |
| Dose Response Trial of Pergolide for Cocaine Dependence - 1 Pergolide - Cocaine-Related Disorders | Phase 3 | Completed | Medical University of South Carolina | 1996-02-01 | 2018-05-16 |
Cocaine-Related Disorders (1) · Parkinson Disease (1)
Medical University of South Carolina (1) · Newron Pharmaceuticals SPA (1)
United States (2) · Argentina (1) · Brazil (1) · Bulgaria (1) · Canada (1) · Chile (1) · Colombia (1) · Croatia (1) · Czechia (1) · Finland (1) · Germany (1) · India (1) · Italy (1) · Mexico (1) · Peru (1)
Jonathan Willmer, MD (1) · Robert Malcolm, M.D. (1)
R01DA008355 (1)